Recent Quotes
View Full List
My Watchlist
Agios Pharmaceuticals, Inc. - Common Stock
Aspen Neuroscience, Inc. - Common Stock
Biddance AI Systems, Inc. - Class A Ordinary Share
Cannabis Global Inc
Chaince Digital Holdings Inc. - American Ordinary Shares
Corgi AMD 2x Daily ETF
Corgi MU 2x Daily ETF
Defiance Daily Target 2X Long IREN ETF
Defiance Daily Target 2X Long SOFI ETF
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
Evernorth Holdings Inc. - Warrants
Evio Inc
Femasys Inc. - Common Stock
Guidewire Software, Inc. Common Stock
Illumina, Inc. - Common Stock
Leverage Shares 2X Long FPS Daily ETF
Liminatus Pharma, Inc. - Class A Common Stock
MicroSectors -3x Short Semiconductor ETNs
OraSure Technologies, Inc. - Common Stock
QVC Group, Inc. - Common Stock
Rush Street Interactive, Inc. Class A Common Stock
Scage Future - American Depositary Shares
Spyre Therapeutics, Inc. - Common Stock
T-REX 2X Long SNOW Daily Target ETF
Tradr 2X Long CLSK Daily ETF
Trio-Tech International - Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
GALDY
)
46.58
UNCHANGED
Delayed Quote
Updated: 3:59 PM EST, Nov 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GALDY
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From
Biotech Insider
Via
GlobeNewswire
Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies
↗
August 19, 2025
Walgreens boosts specialty drug network to 265 therapies, reinforcing its independent market position.
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.